Division of Emergency Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
University of North Carolina Project Malawi, Lilongwe, Central Region, Malawi.
BMJ Paediatr Open. 2022 Apr;6(1). doi: 10.1136/bmjpo-2021-001330.
Although HIV infection, severe malnutrition and hypoxaemia are associated with high mortality in children with WHO-defined severe pneumonia in sub-Saharan Africa, many do not have these conditions and yet mortality remains elevated compared with high-resource settings. Further stratifying mortality risk for children without these conditions could permit more strategic resource utilisation and improved outcomes. We therefore evaluated associations between mortality and clinical characteristics not currently recognised by the WHO as high risk among children in Malawi with severe pneumonia but without HIV (including exposure), severe malnutrition and hypoxaemia.
Between May 2016 and March 2018, we conducted a prospective observational study alongside a randomised controlled trial (CPAP IMPACT) at Salima District Hospital in Malawi. Children aged 1-59 months hospitalised with WHO-defined severe pneumonia without severe malnutrition, HIV and hypoxaemia were enrolled. Study staff assessed children at admission and ascertained hospital outcomes. We compared group characteristics using Student's t-test, rank-sum test, χ test or Fisher's exact test as appropriate.
Among 884 participants, grunting (10/112 (8.9%) vs 11/771 (1.4%)), stridor (2/14 (14.2%) vs 19/870 (2.1%)), haemoglobin <50 g/L (3/27 (11.1%) vs 18/857 (2.1%)) and malaria (11/204 (5.3%) vs 10/673 (1.4%)) were associated with mortality compared with children without these characteristics. Children who survived had a 22 g/L higher mean haemoglobin and 0.7 cm higher mean mid-upper arm circumference (MUAC) than those who died.
In this single-centre study, our analysis identifies potentially modifiable risk factors for mortality among hospitalised Malawian children with severe pneumonia: specific signs of respiratory distress (grunting, stridor), haemoglobin <50 g/L and malaria infection. Significant differences in mean haemoglobin and MUAC were observed between those who survived and those who died. These factors could further stratify mortality risk among hospitalised Malawian children with severe pneumonia lacking recognised high-risk conditions.
尽管在撒哈拉以南非洲,世界卫生组织(WHO)定义的严重肺炎患儿中,HIV 感染、严重营养不良和低氧血症与高死亡率相关,但许多患儿并不存在这些情况,但死亡率仍高于资源丰富的地区。进一步对不具备这些条件的患儿进行死亡风险分层,可能有助于更有针对性地利用资源并改善结局。因此,我们评估了在马拉维,那些患有严重肺炎但不伴有 HIV(包括接触史)、严重营养不良和低氧血症的患儿,与 WHO 认定的高危因素相比,其死亡率与临床特征之间的关系。
2016 年 5 月至 2018 年 3 月,我们在马拉维萨利马区医院开展了一项前瞻性观察性研究,并与一项随机对照试验(CPAP IMPACT)同时进行。患有 WHO 定义的严重肺炎且不伴有严重营养不良、HIV 和低氧血症的 1-59 月龄患儿纳入研究。研究人员在入院时对患儿进行评估,并确定了医院结局。我们使用学生 t 检验、秩和检验、卡方检验或 Fisher 确切概率法,比较了组间特征。
在 884 名患儿中,112 名患儿中有 10 名(8.9%)、771 名患儿中有 11 名(1.4%)出现呻吟、14 名患儿中有 2 名(14.2%)、870 名患儿中有 19 名(2.1%)出现喘鸣、27 名患儿中有 3 名(11.1%)、857 名患儿中有 18 名(2.1%)出现血红蛋白<50g/L、204 名患儿中有 11 名(5.3%)、673 名患儿中有 10 名(1.4%)出现疟疾,这些患儿的死亡率高于不具备这些特征的患儿。与死亡患儿相比,存活患儿的平均血红蛋白高 22g/L,平均上臂中部臂围高 0.7cm。
在这项单中心研究中,我们的分析确定了马拉维严重肺炎住院患儿死亡的潜在可改变的危险因素:特定的呼吸窘迫征象(呻吟、喘鸣)、血红蛋白<50g/L 和疟疾感染。存活患儿与死亡患儿的平均血红蛋白和上臂中部臂围差异显著。这些因素可能有助于进一步对马拉维严重肺炎住院患儿进行死亡风险分层,这些患儿不具备已知的高危条件。